Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Serum polypeptide combination marker, detection kit and method for early warning and/or diagnosis of diabetes

A diagnostic kit and marker technology, applied in biological testing, chemical instruments and methods, disease diagnosis, etc., can solve the problems of lack of marker sensitivity and low specificity, and achieve high sensitivity, high diagnostic specificity, and high development The effect of the applied value

Active Publication Date: 2022-05-31
DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to solve the problems of lack of markers for early warning and diagnosis of diabetes, low sensitivity and low specificity, and to provide a combination of polypeptide markers by using non-targeted peptidomics to discover differential polypeptides and targeted peptidomics verification. Its application and kit in early warning / diagnosis of diabetes, and also provides a method for the quantitative analysis and detection of the above-mentioned combined polypeptide markers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum polypeptide combination marker, detection kit and method for early warning and/or diagnosis of diabetes
  • Serum polypeptide combination marker, detection kit and method for early warning and/or diagnosis of diabetes
  • Serum polypeptide combination marker, detection kit and method for early warning and/or diagnosis of diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The extraction of serum endogenous polypeptides: using ultrafiltration centrifugation. Specific operation process: Take blood from ‑80℃ refrigerator

[0050] Differential polypeptide screening: a total of 163 differential polypeptides were screened. Further select 21 in which the difference fold change is larger

[0052]

[0053]

Embodiment 2

[0057] The extraction of serum endogenous polypeptides: the same as in Example 1.

[0073]

[0074]

[0075]

[0076]

[0077] Note: L represents a light mark, and M represents a successful bid.

[0079] Stability evaluation: The stability of the target polypeptide was further evaluated, and the results showed that 8 polypeptides were placed in a refrigerator at 4°C.

Embodiment 3

[0084] X=712.913-4.476×C(245)+1704×C(244)-2637×(251)-94.36×C(256)-

[0085] Prob (diabetes)=1 / [1+e

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of medical biological detection, in particular to the new application of polypeptide combination markers in the preparation of diabetes diagnostic reagents or kits. The present invention provides a method and kit for quantitatively detecting endogenous polypeptides in serum by using liquid chromatography-mass spectrometry multiple reaction monitoring (multiple reaction monitoring, MRM). Through the reagents and methods of the present invention, it is possible to quantitatively determine the endogenous polypeptides in human serum The content of the eight endogenous polypeptide markers, and then calculate the combined marker variables and the determined cut-off value based on the binary logistic regression equation, for the early warning and / or diagnosis of diabetes. The kit and detection method of the invention have good stability and high specificity, and have the potential of clinical promotion.

Description

Serum polypeptide combination marker and detection test for early warning and / or diagnosis of diabetes Kits and Methods technical field The present invention relates to the diagnosis, prevention and treatment field of medical biological detection technology and metabolic disease, specifically, It is based on the method for quantitative determination of human plasma endogenous polypeptides and the combination of polypeptide markers in the preparation of early warning and / or diagnosis of diabetes. Breakdown kits and methods. Background technique According to the data of International Diabetes Federation in 2017, there are 415 million diabetic patients in the world, of which type 2 diabetes (type 2diabetes, T2DM) accounted for more than 95%. The number of people with diabetes worldwide is expected to increase to 552 million by 2030. Diabetes is the third major disease that endangers human health after cardiovascular disease and tumor. Currently, although the diagnos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68C07K14/47C07K7/08C07K7/06
CPCG01N33/6848G01N33/6893C07K14/47C07K7/06C07K7/08G01N2800/042G01N2800/50
Inventor 吴仁安王莉牛欢
Owner DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products